Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Adenocarcinoma
>>
Novartis
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
patupilone
(EPO 906) / Novartis
Jakafi
(ruxolitinib) / Incyte
CRS-207
/ Novartis
GVAX Pancreas
(allogeneic GM-CSF-secreting tumor cells) / Novartis
dactolisib
(RTB101) / Adicet Bio
buparlisib
(AN2025) / Novartis, Adlai Nortye
GVAX lung cancer vaccine
/ Dana-Farber Cancer Institute, Novartis
Tabrecta
(capmatinib) / Incyte, Novartis
Vynfinit
(vintafolide) / Novartis
bimagrumab
(BYM338) / Novartis, MorphoSys, Eli Lilly
figitumumab
(CP-751,871) / Novartis